NuVasive Gains Clearance for Expanded Use of Attrax Putty
The expanded FDA clearance applies to indications for use with NuVasive's thoracolumbar spinal interbody portfolio....
Jan 05, 2022,
Orthobiologics
ORTHOFLASH 
Neoss Launches NeoGenix XP Bone Substitute
NeoGenix XP more closely resembles natural bone vs. synthetic materials, such as hydroxyapatite or tricalcium phosphate....
Oct 25, 2021,
Access2Bone Announces Accreditation by The American Association of Tissue Banks
The company seeks to supply effective bone void fillers for patients with an exhausted bone metabolism....
Oct 07, 2021,
Orthofix Launches Opus Bone Void Filler
Opus Mg Set is a magnesium-based settable bone void filler for orthopedic procedures. ...
Sep 21, 2021,
Anika’s Tactoset Injectable Bone Substitute Now FDA-Cleared for Hardware Augmentation
The injectable bone substitute is now FDA 510(k) cleared for augmenting suture anchor fixation....
Sep 14, 2021,
Kuros Biosciences Gains FDA 510(k) Clearance for MagnetOs Easypack Putty
The clearance follows existing clearances by the FDA for the use of MagnetOs Granules and MagnetOs Putty in the spine....
Sep 09, 2021,
Royal Biologics Gains FDA 510(k) for Maxx Concentration System
Maxx-PRP is a next-gen device to concentrate autologous whole blood for the safe and rapid preparation of platelet-rich plasma....
Sep 08, 2021,
Study Update: OssDsign Synthetic Bone Graft
The first patient has been treated in a study to investigate OssDsign Catalyst in patients undergoing spinal fusion....
Sep 08, 2021,
Study Results: Bone Therapeutics’ Viscosupplement for Knee OA
The Phase III study with JTA-004 viscosupplement did not meet the primary and consequently the key secondary endpoints....
Aug 30, 2021,
Study Results: Cerapedics’ i-FACTOR vs. Local Autologous Bone in ACDF
Published data show that i-FACTOR is not only cost-effective compared to autograft in ACDF, but is the dominant economic strategy....
Aug 17, 2021,
Loading new posts...
No more posts
